Aurobindo Pharma gets USFDA EIR for Hyderabad facility Ruchika Sharma5 Aug 2022 2:09 PM ISTNew Delhi: Aurobindo Pharma has recently announced that the company has received an Establishment Inspection Report (EIR) from the USFDA with...
Aurobindo Pharma gets 3 USFDA observations for Andhra Pradesh facility Ruchika Sharma3 Aug 2022 1:10 PM ISTHyderabad: Aurobindo Pharma has recently announced that the United States Food and Drug Administration (USFDA) has issued FORM 483 with 3 observations...
Casper Pharma Hyderabad facility concludes USFDA inspection with zero observations Ruchika Sharma31 July 2022 1:00 PM ISTHyderabad: Suven Pharmaceuticals Ltd has announced that the US Food and Drug Administration (USFDA) has completed a pre-approval inspection at Casper...
Granules Pharma US facility gets 6 observations from USFDA Ruchika Sharma23 July 2022 3:57 PM ISTNew Delhi: Drug firm Granules India today announced that the US Food and Drug Administration (USFDA) has issued six observations after the...
Biocon gets 3 USFDA observations for Hyderabad facility Ruchika Sharma22 July 2022 12:50 PM ISTNew Delhi: Pharma major, Biocon has recently announced that the US Food and Drug Administration (USFDA) has concluded a pre-approval inspection...
Lupin Somerset facility gets EIR from USFDA Rahul Verma9 July 2022 6:30 PM ISTGlobal pharma major, Lupin Limited, today announced that the company has received the Establishment Inspection Report (EIR) from United States Food...
Alkem Labs gets 1 observation from USFDA for Indore facility Ruchika Sharma8 July 2022 1:30 PM ISTNew Delhi: Alkem Laboratories Limited has recently announced that the United States Food and Drug Administration (USFDA) has issued Form 483 with...
USFDA issues 2 observations for Dr Reddy's Labs Srikakulam facility Ruchika Sharma8 July 2022 11:31 AM ISTNew Delhi: Drugmaker, Dr Reddy's Laboratories, has recently announced that the United States Food & Drug Administration (USFDA) has...
Lupin gets USFDA EIR for Somerset facility Ruchika Sharma7 July 2022 11:30 AM ISTThe USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI).
Cipla Indore plant gets 2 USFDA observations Ruchika Sharma5 July 2022 12:17 PM ISTMumbai: Pharma major, Cipla, has recently announced that the United States Food and Drug Administration (USFDA) has issued 2 observations after a...
Glenmark gets one USFDA observation for Aurangabad facility Ruchika Sharma2 July 2022 4:29 PM ISTNew Delhi: Glenmark Pharmaceuticals Limited has recently announced that the US Food and Drug Administration (USFDA) has issued Form 483 with...
Glenmark receives 6 USFDA observations for Baddi facility Roshni Dhar24 Jun 2022 6:00 PM ISTDrugmaker, Glenmark Pharmaceuticals Ltd, has recently announced that the US Food and Drug Administration (USFDA) has issued Form 483 with six...
